Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III
Eligible for screening study DCP 001
S1501, Arms 1 & 2 are closed to accrual, effective November 1, 2024 at 1pm PST.
S1501 is reopened to accrual to Arm 3, effective November 5, 2024 with the implementation of Revision 7.